EXPERIENCE APPLICATION SECOND-LINE CHEMOTHERAPY IN THE TREATMENT OF LYMPHOMAS

There is a short review of the modern methods of treatment of lymphomas with unfavorable prognosis. Authors have demonstrated effectiveness of the second line therapy of relapsed and refractory lymphomas. There is a database of treatment of Hodgkin’s and Non-Hodgkins lymphomas with DHAP regimens. According to these data DHAP is effective regimen for Hodgkins and Non-Hodgkins lymphomas with unfavorable prognosis for the majority of patients. This regimen is not very toxic and can be performed in the Department of Oncohematology and Oncology by medical staff.